The government may extend the deadline for drug manufacturers to comply with revised Schedule M standards until December 2025. A final notification is expected soon, allowing MSMEs additional time to ...
Small and medium-sized pharmaceutical companies are preparing to comply with the provisions of the revised Schedule M, which is upgrading facilities and maintaining good manufacturing practices, ...